Hamlet BioPharma AB publ
7ZT
Company Profile
Business description
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.
Contact
Klinikgatan 32
BMC D10
LundSE-222 42
SWET: +46 40122500
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
7
Stocks News & Analysis
stocks
James Hardie transfers of share listing to New York Stock Exchange
The change is a result of the controversial Azek acquisition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,926.20 | 80.60 | -0.89% |
| CAC 40 | 7,763.49 | 59.18 | -0.76% |
| DAX 40 | 24,221.74 | 67.77 | -0.28% |
| Dow JONES (US) | 44,402.17 | 59.98 | 0.14% |
| FTSE 100 | 8,976.97 | 15.15 | -0.17% |
| HKSE | 24,994.14 | 168.48 | 0.68% |
| NASDAQ | 21,037.81 | 142.16 | 0.68% |
| Nikkei 225 | 39,819.11 | 82.08 | -0.21% |
| NZX 50 Index | 12,961.51 | 81.11 | 0.63% |
| S&P 500 | 6,321.70 | 24.91 | 0.40% |
| S&P/ASX 200 | 8,668.20 | 89.00 | -1.02% |
| SSE Composite Index | 3,559.79 | 25.31 | 0.72% |